Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 8.79521912 |
2 | endothelium development (GO:0003158) | 8.40015415 |
3 | definitive hemopoiesis (GO:0060216) | 8.02268904 |
4 | positive regulation of vasculogenesis (GO:2001214) | 7.08543636 |
5 | regulation of sequestering of triglyceride (GO:0010889) | 6.98332936 |
6 | triglyceride catabolic process (GO:0019433) | 6.67006505 |
7 | white fat cell differentiation (GO:0050872) | 6.42916196 |
8 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.11815118 |
9 | brown fat cell differentiation (GO:0050873) | 5.99574217 |
10 | acylglycerol catabolic process (GO:0046464) | 5.98396444 |
11 | neutral lipid catabolic process (GO:0046461) | 5.98396444 |
12 | response to dietary excess (GO:0002021) | 5.75837098 |
13 | positive regulation of fatty acid oxidation (GO:0046321) | 5.65655336 |
14 | blood vessel maturation (GO:0001955) | 5.31303154 |
15 | valine metabolic process (GO:0006573) | 5.29334005 |
16 | lipid particle organization (GO:0034389) | 5.28720302 |
17 | ovulation from ovarian follicle (GO:0001542) | 5.26491536 |
18 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.18994626 |
19 | aggressive behavior (GO:0002118) | 5.18955891 |
20 | fatty acid transmembrane transport (GO:1902001) | 5.16941484 |
21 | positive regulation of vascular permeability (GO:0043117) | 5.09255267 |
22 | biotin metabolic process (GO:0006768) | 5.02946042 |
23 | regulation of vasculogenesis (GO:2001212) | 5.02689688 |
24 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 4.95852782 |
25 | protein heterotrimerization (GO:0070208) | 4.87062963 |
26 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 4.83735588 |
27 | regulation of cholesterol storage (GO:0010885) | 4.77666136 |
28 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.71467125 |
29 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.67226792 |
30 | triglyceride biosynthetic process (GO:0019432) | 4.57542969 |
31 | cell differentiation involved in metanephros development (GO:0072202) | 4.56430111 |
32 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.50827072 |
33 | fatty acid beta-oxidation (GO:0006635) | 4.46928422 |
34 | acylglycerol biosynthetic process (GO:0046463) | 4.46644032 |
35 | neutral lipid biosynthetic process (GO:0046460) | 4.46644032 |
36 | lipid storage (GO:0019915) | 4.41927075 |
37 | carnitine shuttle (GO:0006853) | 4.40995681 |
38 | glomerular basement membrane development (GO:0032836) | 4.40423331 |
39 | glycerolipid catabolic process (GO:0046503) | 4.34358414 |
40 | epithelial cell differentiation involved in kidney development (GO:0035850) | 4.32817598 |
41 | positive regulation of odontogenesis (GO:0042482) | 4.29149505 |
42 | regulation of fatty acid oxidation (GO:0046320) | 4.15717169 |
43 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.15140562 |
44 | cellular response to antibiotic (GO:0071236) | 4.07323304 |
45 | angiogenesis involved in wound healing (GO:0060055) | 3.98066455 |
46 | fatty acid homeostasis (GO:0055089) | 3.87632736 |
47 | extracellular fibril organization (GO:0043206) | 3.87083164 |
48 | response to vitamin E (GO:0033197) | 3.86836580 |
49 | positive regulation of glucose import (GO:0046326) | 3.85150548 |
50 | fatty acid oxidation (GO:0019395) | 3.84069504 |
51 | growth hormone receptor signaling pathway (GO:0060396) | 3.82932910 |
52 | negative regulation of vascular permeability (GO:0043116) | 3.81818533 |
53 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.79855328 |
54 | lipid oxidation (GO:0034440) | 3.76318813 |
55 | glomerular visceral epithelial cell development (GO:0072015) | 3.76241789 |
56 | positive regulation of B cell differentiation (GO:0045579) | 3.75733678 |
57 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.75005067 |
58 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.74764441 |
59 | cellular response to vitamin (GO:0071295) | 3.72796077 |
60 | negative regulation of protein autophosphorylation (GO:0031953) | 3.71881431 |
61 | progesterone metabolic process (GO:0042448) | 3.69583697 |
62 | fatty acid catabolic process (GO:0009062) | 3.69478249 |
63 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.66242311 |
64 | cellular response to exogenous dsRNA (GO:0071360) | 3.64176470 |
65 | megakaryocyte development (GO:0035855) | 3.63379888 |
66 | triglyceride metabolic process (GO:0006641) | 3.60169518 |
67 | glomerular filtration (GO:0003094) | 3.56124425 |
68 | interkinetic nuclear migration (GO:0022027) | 3.55204577 |
69 | renal filtration (GO:0097205) | 3.54732730 |
70 | positive regulation of lipid catabolic process (GO:0050996) | 3.54117616 |
71 | coenzyme A biosynthetic process (GO:0015937) | 3.53618173 |
72 | hematopoietic stem cell proliferation (GO:0071425) | 3.53581093 |
73 | glycerol metabolic process (GO:0006071) | 3.53280511 |
74 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.53201497 |
75 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.52787516 |
76 | thrombin receptor signaling pathway (GO:0070493) | 3.50969339 |
77 | carnitine transmembrane transport (GO:1902603) | 3.46000545 |
78 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.45577977 |
79 | acylglycerol metabolic process (GO:0006639) | 3.44725626 |
80 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.44385401 |
81 | branched-chain amino acid metabolic process (GO:0009081) | 3.42582367 |
82 | lymph vessel development (GO:0001945) | 3.42361522 |
83 | sprouting angiogenesis (GO:0002040) | 3.41060142 |
84 | neutral lipid metabolic process (GO:0006638) | 3.40029343 |
85 | plasma lipoprotein particle clearance (GO:0034381) | 3.39180084 |
86 | negative regulation of phagocytosis (GO:0050765) | 3.35333808 |
87 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.35050714 |
88 | apoptotic cell clearance (GO:0043277) | 3.32681787 |
89 | positive regulation of glomerulus development (GO:0090193) | 3.31958334 |
90 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.30273101 |
91 | negative regulation of granulocyte differentiation (GO:0030853) | 3.30149889 |
92 | diacylglycerol metabolic process (GO:0046339) | 3.29907536 |
93 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.29846539 |
94 | glomerular epithelial cell development (GO:0072310) | 3.28065749 |
95 | cellular response to growth hormone stimulus (GO:0071378) | 3.27519551 |
96 | cellular response to lithium ion (GO:0071285) | 3.25707570 |
97 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.25501841 |
98 | thyroid gland development (GO:0030878) | 3.23018620 |
99 | fibril organization (GO:0097435) | 3.22457738 |
100 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.21811665 |
101 | keratan sulfate catabolic process (GO:0042340) | 3.21536212 |
102 | phagocytosis, recognition (GO:0006910) | 3.21243444 |
103 | alpha-linolenic acid metabolic process (GO:0036109) | 3.20277162 |
104 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.19599775 |
105 | UV protection (GO:0009650) | 3.19558304 |
106 | regulation of female gonad development (GO:2000194) | 3.18592721 |
107 | positive regulation of lipid storage (GO:0010884) | 3.18202204 |
108 | positive regulation of glucose transport (GO:0010828) | 3.17377018 |
109 | androgen biosynthetic process (GO:0006702) | 3.17259776 |
110 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.17025469 |
111 | collagen fibril organization (GO:0030199) | 3.16883859 |
112 | branched-chain amino acid catabolic process (GO:0009083) | 3.16282037 |
113 | amino-acid betaine transport (GO:0015838) | 3.14338968 |
114 | carnitine transport (GO:0015879) | 3.14338968 |
115 | drinking behavior (GO:0042756) | 3.13441375 |
116 | negative regulation of metanephros development (GO:0072217) | 3.13421343 |
117 | acyl-CoA biosynthetic process (GO:0071616) | 3.13344631 |
118 | thioester biosynthetic process (GO:0035384) | 3.13344631 |
119 | heparin biosynthetic process (GO:0030210) | 3.11369899 |
120 | heparin metabolic process (GO:0030202) | 3.11369899 |
121 | positive regulation of transforming growth factor beta production (GO:0071636) | 3.08699363 |
122 | nephron epithelium development (GO:0072009) | 3.07875309 |
123 | alditol metabolic process (GO:0019400) | 3.06151921 |
124 | mature B cell differentiation involved in immune response (GO:0002313) | 3.05024311 |
125 | regulation of gonadotropin secretion (GO:0032276) | 3.04686399 |
126 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.04568454 |
127 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.03770924 |
128 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.02874200 |
129 | axon extension involved in axon guidance (GO:0048846) | 3.02874200 |
130 | quaternary ammonium group transport (GO:0015697) | 3.02571928 |
131 | endothelial cell proliferation (GO:0001935) | 3.00745604 |
132 | negative regulation of lipid storage (GO:0010888) | 3.00256450 |
133 | ovulation (GO:0030728) | 2.99571945 |
134 | oxaloacetate metabolic process (GO:0006107) | 2.99418193 |
135 | positive regulation of macrophage cytokine production (GO:0060907) | 2.98361368 |
136 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.98083616 |
137 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.97305238 |
138 | intracellular lipid transport (GO:0032365) | 2.95422597 |
139 | negative regulation of amino acid transport (GO:0051956) | 2.93003028 |
140 | regulation of vascular permeability (GO:0043114) | 2.92935858 |
141 | pinocytosis (GO:0006907) | 2.92238334 |
142 | cellular response to epinephrine stimulus (GO:0071872) | 2.92120470 |
143 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.91924369 |
144 | positive regulation of histone deacetylation (GO:0031065) | 2.91835827 |
145 | tricarboxylic acid metabolic process (GO:0072350) | 2.91186037 |
146 | endodermal cell differentiation (GO:0035987) | 2.91001927 |
147 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.90705545 |
148 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.89733228 |
149 | negative regulation of digestive system process (GO:0060457) | 2.85626869 |
150 | negative regulation of macrophage differentiation (GO:0045650) | 2.80495982 |
151 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.74619351 |
152 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.73040555 |
153 | response to growth hormone (GO:0060416) | 2.67014672 |
154 | histamine secretion (GO:0001821) | 2.65090789 |
155 | hemoglobin metabolic process (GO:0020027) | 2.65078388 |
156 | regulation of female receptivity (GO:0045924) | 2.64854718 |
157 | dermatan sulfate metabolic process (GO:0030205) | 2.62210622 |
158 | hemopoiesis (GO:0030097) | 2.61368147 |
159 | metanephric mesenchyme development (GO:0072075) | 2.60532637 |
160 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.60330750 |
161 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.59583598 |
162 | cyclooxygenase pathway (GO:0019371) | 2.57971290 |
163 | response to epinephrine (GO:0071871) | 2.57516147 |
164 | mannose metabolic process (GO:0006013) | 2.57496356 |
165 | estrogen biosynthetic process (GO:0006703) | 2.56515222 |
166 | protein localization to cell surface (GO:0034394) | 2.53935628 |
167 | histamine transport (GO:0051608) | 2.53888893 |
168 | cellular response to toxic substance (GO:0097237) | 2.53293528 |
169 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.52684942 |
170 | negative regulation of cell size (GO:0045792) | 2.52518300 |
171 | regulation of erythrocyte differentiation (GO:0045646) | 2.51425208 |
172 | regulation of integrin activation (GO:0033623) | 2.51227137 |
173 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.51180277 |
174 | embryonic viscerocranium morphogenesis (GO:0048703) | 2.50910367 |
175 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.49313823 |
176 | regulation of granulocyte differentiation (GO:0030852) | 2.48285244 |
177 | positive regulation of granulocyte differentiation (GO:0030854) | 2.47309146 |
178 | cell migration involved in heart development (GO:0060973) | 2.45072238 |
179 | gap junction assembly (GO:0016264) | 2.44843996 |
180 | hepatocyte differentiation (GO:0070365) | 2.44523096 |
181 | endothelial cell morphogenesis (GO:0001886) | 2.43966195 |
182 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.42851249 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.40797028 |
2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.36110431 |
3 | * CLOCK_20551151_ChIP-Seq_293T_Human | 4.27938605 |
4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.88590423 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82148138 |
6 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.62207088 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52692914 |
8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.33819365 |
9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.21629902 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.13496943 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.73250023 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56533213 |
13 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.47050431 |
14 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.45243802 |
15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.34717184 |
16 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.03591208 |
17 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.00013826 |
18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 11.9368484 |
19 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.96821333 |
20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95310796 |
21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92401304 |
22 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.88655073 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83802333 |
24 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.82667850 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79546736 |
26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79344900 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76632816 |
28 | CJUN_26792858_Chip-Seq_BT549_Human | 1.74949713 |
29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73413599 |
30 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72794274 |
31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71481374 |
32 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71080656 |
33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.68839829 |
34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65032814 |
35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.63210066 |
36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.63113835 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.59999550 |
38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.59532257 |
39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.57966964 |
40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56700890 |
41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54518011 |
42 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53762388 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51170217 |
44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47925567 |
45 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47925567 |
46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.46595605 |
47 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46203195 |
48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41651095 |
49 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.39941753 |
50 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39240757 |
51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.37816132 |
52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.37816132 |
53 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.35922953 |
54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35804484 |
55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.35039140 |
56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34223507 |
57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33539019 |
58 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33135027 |
59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32158284 |
60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.30349775 |
61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29526684 |
62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29128183 |
63 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28708380 |
64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27969951 |
65 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26274575 |
66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25396555 |
67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25335968 |
68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23805177 |
69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23205417 |
70 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22806995 |
71 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.22685891 |
72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.22611840 |
73 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21056640 |
74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20362886 |
75 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20268068 |
76 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20268068 |
77 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.19864270 |
78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19602120 |
79 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.19004868 |
80 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15810101 |
81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15463965 |
82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14781531 |
83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13545284 |
84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13542392 |
85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.11977060 |
86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09753358 |
87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09147891 |
88 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08485303 |
89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07992357 |
90 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05717329 |
91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03496144 |
92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02960721 |
93 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99286904 |
94 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96442650 |
95 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96342270 |
96 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95942575 |
97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95052861 |
98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94259821 |
99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93987913 |
100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93047908 |
101 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.92320751 |
102 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91409977 |
103 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90502516 |
104 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.90032326 |
105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89340951 |
106 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88400082 |
107 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87768365 |
108 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87365888 |
109 | MYB_26560356_Chip-Seq_TH2_Human | 0.85551063 |
110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.85341138 |
111 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84654792 |
112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84489277 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84246324 |
114 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83818968 |
115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83818968 |
116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83672053 |
117 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.83137667 |
118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82480177 |
119 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.82178675 |
120 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82147489 |
121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81799756 |
122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.81454606 |
123 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.81352322 |
124 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81140490 |
125 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.80981584 |
126 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.80596449 |
127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80593302 |
128 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.80270398 |
129 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80221849 |
130 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79870435 |
131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.79312142 |
132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.79179489 |
133 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78431955 |
134 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77996374 |
135 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.77556333 |
136 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77233181 |
137 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76315346 |
138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.75393705 |
139 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74920851 |
140 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.74894254 |
141 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74844232 |
142 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73829644 |
143 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72064494 |
144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71706218 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005670_abnormal_white_adipose | 7.36293900 |
2 | MP0008438_abnormal_cutaneous_collagen | 6.02450255 |
3 | MP0005666_abnormal_adipose_tissue | 4.98104764 |
4 | MP0004130_abnormal_muscle_cell | 4.47427730 |
5 | MP0004185_abnormal_adipocyte_glucose | 4.16026967 |
6 | MP0005275_abnormal_skin_tensile | 3.79966448 |
7 | * MP0005375_adipose_tissue_phenotype | 3.51490263 |
8 | MP0002837_dystrophic_cardiac_calcinosis | 3.27808561 |
9 | MP0004272_abnormal_basement_membrane | 3.18937020 |
10 | MP0006054_spinal_hemorrhage | 3.14946974 |
11 | MP0002876_abnormal_thyroid_physiology | 3.03769731 |
12 | MP0002396_abnormal_hematopoietic_system | 2.88779344 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.81309361 |
14 | MP0002971_abnormal_brown_adipose | 2.60264544 |
15 | MP0009115_abnormal_fat_cell | 2.54238498 |
16 | MP0004808_abnormal_hematopoietic_stem | 2.45404929 |
17 | MP0010329_abnormal_lipoprotein_level | 2.21546111 |
18 | * MP0000003_abnormal_adipose_tissue | 2.14575026 |
19 | MP0001661_extended_life_span | 2.09262521 |
20 | MP0003191_abnormal_cellular_cholesterol | 2.07914090 |
21 | * MP0005334_abnormal_fat_pad | 1.81876271 |
22 | MP0002970_abnormal_white_adipose | 1.78541344 |
23 | MP0000465_gastrointestinal_hemorrhage | 1.75352429 |
24 | MP0003959_abnormal_lean_body | 1.74689966 |
25 | MP0000767_abnormal_smooth_muscle | 1.71585499 |
26 | MP0003828_pulmonary_edema | 1.59650339 |
27 | MP0003690_abnormal_glial_cell | 1.56145687 |
28 | MP0001545_abnormal_hematopoietic_system | 1.54936839 |
29 | MP0005397_hematopoietic_system_phenotyp | 1.54936839 |
30 | MP0009780_abnormal_chondrocyte_physiolo | 1.54092683 |
31 | MP0005165_increased_susceptibility_to | 1.52358517 |
32 | * MP0000013_abnormal_adipose_tissue | 1.52217445 |
33 | MP0001879_abnormal_lymphatic_vessel | 1.50789237 |
34 | MP0006138_congestive_heart_failure | 1.49765860 |
35 | MP0002118_abnormal_lipid_homeostasis | 1.49759951 |
36 | MP0003566_abnormal_cell_adhesion | 1.46591447 |
37 | MP0005623_abnormal_meninges_morphology | 1.45727075 |
38 | MP0003045_fibrosis | 1.40396817 |
39 | MP0005535_abnormal_body_temperature | 1.37208975 |
40 | MP0003279_aneurysm | 1.36023963 |
41 | MP0001958_emphysema | 1.34803488 |
42 | MP0008004_abnormal_stomach_pH | 1.32208390 |
43 | MP0005503_abnormal_tendon_morphology | 1.30942902 |
44 | MP0009250_abnormal_appendicular_skeleto | 1.30307028 |
45 | MP0009278_abnormal_bone_marrow | 1.29068319 |
46 | MP0005464_abnormal_platelet_physiology | 1.28744377 |
47 | MP0009697_abnormal_copulation | 1.27731709 |
48 | MP0008775_abnormal_heart_ventricle | 1.25575848 |
49 | MP0002166_altered_tumor_susceptibility | 1.22939636 |
50 | MP0000751_myopathy | 1.22768946 |
51 | MP0002060_abnormal_skin_morphology | 1.20826770 |
52 | MP0003724_increased_susceptibility_to | 1.19284453 |
53 | MP0002295_abnormal_pulmonary_circulatio | 1.16626884 |
54 | MP0004215_abnormal_myocardial_fiber | 1.14738374 |
55 | MP0005385_cardiovascular_system_phenoty | 1.13007063 |
56 | MP0001544_abnormal_cardiovascular_syste | 1.13007063 |
57 | MP0004084_abnormal_cardiac_muscle | 1.11248745 |
58 | MP0005448_abnormal_energy_balance | 1.10654551 |
59 | MP0003186_abnormal_redox_activity | 1.09908816 |
60 | MP0005620_abnormal_muscle_contractility | 1.09548964 |
61 | MP0009384_cardiac_valve_regurgitation | 1.06845315 |
62 | MP0004087_abnormal_muscle_fiber | 1.06485332 |
63 | MP0002108_abnormal_muscle_morphology | 1.05398696 |
64 | MP0005452_abnormal_adipose_tissue | 1.04688681 |
65 | MP0000681_abnormal_thyroid_gland | 1.02490425 |
66 | MP0005023_abnormal_wound_healing | 1.01206018 |
67 | MP0002933_joint_inflammation | 1.01033666 |
68 | MP0000750_abnormal_muscle_regeneration | 1.00908341 |
69 | MP0003950_abnormal_plasma_membrane | 1.00843059 |
70 | MP0002909_abnormal_adrenal_gland | 1.00636010 |
71 | MP0010368_abnormal_lymphatic_system | 1.00376389 |
72 | MP0002168_other_aberrant_phenotype | 0.97350026 |
73 | MP0000343_altered_response_to | 0.96757302 |
74 | MP0001727_abnormal_embryo_implantation | 0.96186453 |
75 | MP0000759_abnormal_skeletal_muscle | 0.95110069 |
76 | * MP0000230_abnormal_systemic_arterial | 0.94419337 |
77 | MP0004134_abnormal_chest_morphology | 0.93485997 |
78 | MP0001501_abnormal_sleep_pattern | 0.90390743 |
79 | MP0004782_abnormal_surfactant_physiolog | 0.89999986 |
80 | MP0002972_abnormal_cardiac_muscle | 0.89508049 |
81 | MP0002006_tumorigenesis | 0.87966504 |
82 | MP0005390_skeleton_phenotype | 0.87265198 |
83 | MP0002127_abnormal_cardiovascular_syste | 0.87172644 |
84 | MP0002160_abnormal_reproductive_system | 0.86287330 |
85 | MP0005330_cardiomyopathy | 0.85574248 |
86 | MP0002925_abnormal_cardiovascular_devel | 0.84924234 |
87 | MP0002078_abnormal_glucose_homeostasis | 0.84461866 |
88 | MP0000609_abnormal_liver_physiology | 0.81700454 |
89 | MP0003091_abnormal_cell_migration | 0.79951462 |
90 | MP0005379_endocrine/exocrine_gland_phen | 0.79611670 |
91 | MP0004036_abnormal_muscle_relaxation | 0.79327369 |
92 | MP0003656_abnormal_erythrocyte_physiolo | 0.78449721 |
93 | MP0003385_abnormal_body_wall | 0.77262100 |
94 | MP0005164_abnormal_response_to | 0.74908149 |
95 | MP0001542_abnormal_bone_strength | 0.74545206 |
96 | MP0001177_atelectasis | 0.74433430 |
97 | MP0001881_abnormal_mammary_gland | 0.73959640 |
98 | MP0005388_respiratory_system_phenotype | 0.73713042 |
99 | MP0002133_abnormal_respiratory_system | 0.73713042 |
100 | MP0010630_abnormal_cardiac_muscle | 0.73632930 |
101 | MP0005167_abnormal_blood-brain_barrier | 0.73632445 |
102 | MP0003948_abnormal_gas_homeostasis | 0.73368738 |
103 | MP0000266_abnormal_heart_morphology | 0.73045812 |
104 | MP0003300_gastrointestinal_ulcer | 0.72614423 |
105 | MP0005595_abnormal_vascular_smooth | 0.71037323 |
106 | MP0003943_abnormal_hepatobiliary_system | 0.70823292 |
107 | * MP0002115_abnormal_skeleton_extremities | 0.70626919 |
108 | MP0001175_abnormal_lung_morphology | 0.70123008 |
109 | MP0004147_increased_porphyrin_level | 0.68163420 |
110 | * MP0001784_abnormal_fluid_regulation | 0.67743229 |
111 | MP0005171_absent_coat_pigmentation | 0.67484357 |
112 | MP0002932_abnormal_joint_morphology | 0.67257993 |
113 | MP0001243_abnormal_dermal_layer | 0.67111381 |
114 | MP0002332_abnormal_exercise_endurance | 0.66089659 |
115 | MP0004085_abnormal_heartbeat | 0.66061493 |
116 | MP0002009_preneoplasia | 0.65011778 |
117 | MP0010352_gastrointestinal_tract_polyps | 0.63030376 |
118 | MP0008007_abnormal_cellular_replicative | 0.60808340 |
119 | MP0002254_reproductive_system_inflammat | 0.60770013 |
120 | MP0002796_impaired_skin_barrier | 0.60381838 |
121 | * MP0000163_abnormal_cartilage_morphology | 0.60094709 |
122 | MP0001915_intracranial_hemorrhage | 0.58325971 |
123 | MP0005084_abnormal_gallbladder_morpholo | 0.56563548 |
124 | MP0001849_ear_inflammation | 0.55985379 |
125 | MP0001614_abnormal_blood_vessel | 0.55968456 |
126 | MP0005409_darkened_coat_color | 0.55876303 |
127 | MP0000749_muscle_degeneration | 0.55311789 |
128 | MP0005365_abnormal_bile_salt | 0.54934097 |
129 | * MP0002113_abnormal_skeleton_development | 0.54897416 |
130 | MP0000733_abnormal_muscle_development | 0.54760636 |
131 | MP0002877_abnormal_melanocyte_morpholog | 0.54350699 |
132 | MP0008961_abnormal_basal_metabolism | 0.53683977 |
133 | MP0001299_abnormal_eye_distance/ | 0.53376357 |
134 | MP0004484_altered_response_of | 0.53266498 |
135 | MP0000858_altered_metastatic_potential | 0.52398936 |
136 | MP0000249_abnormal_blood_vessel | 0.52354996 |
137 | MP0002896_abnormal_bone_mineralization | 0.50415389 |
138 | * MP0002128_abnormal_blood_circulation | 0.50023844 |
139 | MP0002638_abnormal_pupillary_reflex | 0.49930339 |
140 | MP0005076_abnormal_cell_differentiation | 0.48690870 |
141 | MP0003646_muscle_fatigue | 0.47368468 |
142 | MP0005369_muscle_phenotype | 0.46740388 |
143 | MP0005508_abnormal_skeleton_morphology | 0.46135868 |
144 | MP0009672_abnormal_birth_weight | 0.45712038 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oligomenorrhea (HP:0000876) | 7.05844760 |
2 | Acanthosis nigricans (HP:0000956) | 6.40063166 |
3 | Hypertriglyceridemia (HP:0002155) | 5.06300603 |
4 | Premature rupture of membranes (HP:0001788) | 4.40369089 |
5 | Increased connective tissue (HP:0009025) | 3.94439554 |
6 | Cerebral aneurysm (HP:0004944) | 3.81896574 |
7 | Hyperglycinuria (HP:0003108) | 3.80683905 |
8 | Protrusio acetabuli (HP:0003179) | 3.78122993 |
9 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.70001370 |
10 | Broad metatarsal (HP:0001783) | 3.63878367 |
11 | Ankle contracture (HP:0006466) | 3.59337957 |
12 | Difficulty running (HP:0009046) | 3.54589329 |
13 | Atrioventricular block (HP:0001678) | 3.50640986 |
14 | Broad ribs (HP:0000885) | 3.34290296 |
15 | Spondylolisthesis (HP:0003302) | 3.28589043 |
16 | Long foot (HP:0001833) | 3.28217815 |
17 | Aortic dissection (HP:0002647) | 3.27067590 |
18 | Pigmentary retinal degeneration (HP:0001146) | 3.25748256 |
19 | Shallow orbits (HP:0000586) | 3.20071423 |
20 | Aortic aneurysm (HP:0004942) | 3.17459770 |
21 | Acute lymphatic leukemia (HP:0006721) | 3.13396614 |
22 | Myoglobinuria (HP:0002913) | 3.08751772 |
23 | Abnormality of glycine metabolism (HP:0010895) | 3.07771520 |
24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07771520 |
25 | Mesangial abnormality (HP:0001966) | 3.05549878 |
26 | Muscle fiber splitting (HP:0003555) | 3.00888020 |
27 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.00430235 |
28 | Wormian bones (HP:0002645) | 3.00141937 |
29 | Bone cyst (HP:0012062) | 2.97813178 |
30 | Hemorrhage of the eye (HP:0011885) | 2.96708269 |
31 | Aortic regurgitation (HP:0001659) | 2.95951844 |
32 | Hyperthyroidism (HP:0000836) | 2.95803838 |
33 | Increased variability in muscle fiber diameter (HP:0003557) | 2.94202827 |
34 | Hydroxyprolinuria (HP:0003080) | 2.93995640 |
35 | Abnormality of proline metabolism (HP:0010907) | 2.93995640 |
36 | Vascular tortuosity (HP:0004948) | 2.92720749 |
37 | Subcapsular cataract (HP:0000523) | 2.92408079 |
38 | Growth hormone excess (HP:0000845) | 2.90661394 |
39 | Joint stiffness (HP:0001387) | 2.89200831 |
40 | Spinal rigidity (HP:0003306) | 2.86976177 |
41 | Type 1 muscle fiber predominance (HP:0003803) | 2.85587818 |
42 | Insulin resistance (HP:0000855) | 2.81133966 |
43 | Lipoatrophy (HP:0100578) | 2.81004731 |
44 | Mitral valve prolapse (HP:0001634) | 2.71271031 |
45 | Soft skin (HP:0000977) | 2.69978003 |
46 | Dilatation of the ascending aorta (HP:0005111) | 2.66743238 |
47 | Arterial tortuosity (HP:0005116) | 2.63089798 |
48 | Lymphangioma (HP:0100764) | 2.61998276 |
49 | Myocardial infarction (HP:0001658) | 2.59419359 |
50 | Relative macrocephaly (HP:0004482) | 2.57393157 |
51 | Hypoalphalipoproteinemia (HP:0003233) | 2.56956691 |
52 | Venous abnormality (HP:0002624) | 2.56524364 |
53 | Genu recurvatum (HP:0002816) | 2.55292651 |
54 | Large hands (HP:0001176) | 2.54015164 |
55 | Hyporeflexia of lower limbs (HP:0002600) | 2.52489810 |
56 | Hematochezia (HP:0002573) | 2.51350022 |
57 | Distal arthrogryposis (HP:0005684) | 2.50799478 |
58 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49845778 |
59 | Acute myeloid leukemia (HP:0004808) | 2.49094863 |
60 | Biconcave vertebral bodies (HP:0004586) | 2.45168937 |
61 | Infantile muscular hypotonia (HP:0008947) | 2.42832120 |
62 | Joint laxity (HP:0001388) | 2.41625419 |
63 | Atrophic scars (HP:0001075) | 2.41075142 |
64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.37680655 |
65 | Facial diplegia (HP:0001349) | 2.37674629 |
66 | Rectal prolapse (HP:0002035) | 2.36431877 |
67 | Complement deficiency (HP:0004431) | 2.35873668 |
68 | Venous insufficiency (HP:0005293) | 2.35382999 |
69 | Abnormality of dentin (HP:0010299) | 2.35224130 |
70 | Multiple enchondromatosis (HP:0005701) | 2.35177192 |
71 | Aneurysm (HP:0002617) | 2.34916761 |
72 | Round ear (HP:0100830) | 2.34686595 |
73 | Hypokalemic alkalosis (HP:0001949) | 2.34461307 |
74 | Right ventricular cardiomyopathy (HP:0011663) | 2.33565240 |
75 | Hypoplasia of the iris (HP:0007676) | 2.31966890 |
76 | Hypoglycemic coma (HP:0001325) | 2.30534724 |
77 | Follicular hyperkeratosis (HP:0007502) | 2.30298162 |
78 | Rhabdomyolysis (HP:0003201) | 2.30144577 |
79 | Ketoacidosis (HP:0001993) | 2.29243630 |
80 | Buphthalmos (HP:0000557) | 2.27297105 |
81 | Scapular winging (HP:0003691) | 2.27090201 |
82 | Metaphyseal dysplasia (HP:0100255) | 2.26499939 |
83 | Syringomyelia (HP:0003396) | 2.26106443 |
84 | Spinal cord lesions (HP:0100561) | 2.26106443 |
85 | Heart block (HP:0012722) | 2.24421769 |
86 | Abnormal atrioventricular conduction (HP:0005150) | 2.22934946 |
87 | Abnormality of the acetabulum (HP:0003170) | 2.22167426 |
88 | Abnormal cartilage morphology (HP:0002763) | 2.22161107 |
89 | Thoracolumbar scoliosis (HP:0002944) | 2.21686524 |
90 | Redundant skin (HP:0001582) | 2.18951206 |
91 | Fragile skin (HP:0001030) | 2.18587011 |
92 | Type 2 muscle fiber atrophy (HP:0003554) | 2.18383913 |
93 | Polar cataract (HP:0010696) | 2.17990913 |
94 | Hyperpituitarism (HP:0010514) | 2.15376926 |
95 | Abnormality of skull ossification (HP:0002703) | 2.15340845 |
96 | Accelerated skeletal maturation (HP:0005616) | 2.14809535 |
97 | Panhypogammaglobulinemia (HP:0003139) | 2.14752946 |
98 | Prominent supraorbital ridges (HP:0000336) | 2.13549290 |
99 | Skin nodule (HP:0200036) | 2.12001621 |
100 | Abnormal delivery (HP:0001787) | 2.11789531 |
101 | Epidermoid cyst (HP:0200040) | 2.11644706 |
102 | Ectopia lentis (HP:0001083) | 2.11616155 |
103 | Wide anterior fontanel (HP:0000260) | 2.11287539 |
104 | Decreased skull ossification (HP:0004331) | 2.10868169 |
105 | Thyroid-stimulating hormone excess (HP:0002925) | 2.10528516 |
106 | Focal segmental glomerulosclerosis (HP:0000097) | 2.10476486 |
107 | Abnormality of the right ventricle (HP:0001707) | 2.09508340 |
108 | Elbow flexion contracture (HP:0002987) | 2.09135985 |
109 | Striae distensae (HP:0001065) | 2.07155548 |
110 | Proximal amyotrophy (HP:0007126) | 2.06446256 |
111 | Ovoid vertebral bodies (HP:0003300) | 2.04999406 |
112 | Peritonitis (HP:0002586) | 2.04980108 |
113 | Spinal canal stenosis (HP:0003416) | 2.04752291 |
114 | Osteolytic defects of the hand bones (HP:0009699) | 2.04663225 |
115 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04663225 |
116 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03597889 |
117 | Mucopolysacchariduria (HP:0008155) | 2.03597889 |
118 | Keratoconus (HP:0000563) | 2.02879433 |
119 | Increased corneal curvature (HP:0100692) | 2.02879433 |
120 | Bladder diverticulum (HP:0000015) | 2.02467732 |
121 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01032702 |
122 | Breech presentation (HP:0001623) | 2.00802599 |
123 | Blue sclerae (HP:0000592) | 2.00741663 |
124 | Nephritis (HP:0000123) | 2.00138248 |
125 | Vertebral compression fractures (HP:0002953) | 1.99975753 |
126 | Ketosis (HP:0001946) | 1.99536200 |
127 | Aortic valve stenosis (HP:0001650) | 1.98759583 |
128 | Enlarged penis (HP:0000040) | 1.98429443 |
129 | Congenital hip dislocation (HP:0001374) | 1.97900576 |
130 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.97140687 |
131 | Tetraparesis (HP:0002273) | 1.97023212 |
132 | Flared iliac wings (HP:0002869) | 1.95056495 |
133 | Cupped ribs (HP:0000887) | 1.94604215 |
134 | Neonatal short-limb short stature (HP:0008921) | 1.94386198 |
135 | Prolonged bleeding time (HP:0003010) | 1.93841176 |
136 | Testicular atrophy (HP:0000029) | 1.91847372 |
137 | Decreased subcutaneous fat (HP:0001002) | 1.91752753 |
138 | Abnormal eating behavior (HP:0100738) | 1.91606738 |
139 | Muscle fiber atrophy (HP:0100295) | 1.91538817 |
140 | Morphological abnormality of the middle ear (HP:0008609) | 1.89984875 |
141 | Glucose intolerance (HP:0000833) | 1.89861726 |
142 | Overgrowth (HP:0001548) | 1.89024525 |
143 | Absent frontal sinuses (HP:0002688) | 1.87145222 |
144 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86149509 |
145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86149509 |
146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86149509 |
147 | Turricephaly (HP:0000262) | 1.86145565 |
148 | Mitral regurgitation (HP:0001653) | 1.85863303 |
149 | Hyperextensible skin (HP:0000974) | 1.85483547 |
150 | Mesomelia (HP:0003027) | 1.85275941 |
151 | Abnormality of the 4th metacarpal (HP:0010012) | 1.84077950 |
152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84039569 |
153 | Bowel diverticulosis (HP:0005222) | 1.83889596 |
154 | Knee flexion contracture (HP:0006380) | 1.83468926 |
155 | Hypoalbuminemia (HP:0003073) | 1.81623818 |
156 | Abnormal albumin level (HP:0012116) | 1.81623818 |
157 | Renal salt wasting (HP:0000127) | 1.80844124 |
158 | Cervical subluxation (HP:0003308) | 1.80677674 |
159 | Premature skin wrinkling (HP:0100678) | 1.80417607 |
160 | Abnormality of the costochondral junction (HP:0000919) | 1.80092143 |
161 | Bulbous nose (HP:0000414) | 1.79833715 |
162 | Resting tremor (HP:0002322) | 1.78597762 |
163 | Calcaneovalgus deformity (HP:0001848) | 1.76870992 |
164 | Abnormal hemoglobin (HP:0011902) | 1.76296350 |
165 | Hyperglycemia (HP:0003074) | 1.75731085 |
166 | Deformed tarsal bones (HP:0008119) | 1.75456816 |
167 | Myotonia (HP:0002486) | 1.75035067 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CAMK1D | 5.38094695 |
2 | TRIB3 | 5.09979519 |
3 | SIK1 | 4.05984270 |
4 | KIT | 3.92800377 |
5 | CAMK1G | 3.89866176 |
6 | RIPK1 | 2.79551218 |
7 | BCKDK | 2.70894726 |
8 | TAOK3 | 2.64605431 |
9 | LMTK2 | 2.61181450 |
10 | TIE1 | 2.40694977 |
11 | TEC | 2.36866197 |
12 | PDK3 | 2.35733789 |
13 | PDK4 | 2.35733789 |
14 | PDGFRA | 2.27103222 |
15 | FRK | 2.21780303 |
16 | PIK3CG | 2.19397229 |
17 | DDR2 | 2.14940662 |
18 | FGFR2 | 2.14323615 |
19 | EPHB2 | 2.13872566 |
20 | TTN | 2.11605258 |
21 | FES | 2.04136125 |
22 | LATS1 | 2.01625033 |
23 | FGFR3 | 1.86261920 |
24 | MST1R | 1.85663739 |
25 | MAP2K3 | 1.83982922 |
26 | PIK3CA | 1.78931053 |
27 | TGFBR2 | 1.68814399 |
28 | RPS6KB2 | 1.66145490 |
29 | PDK2 | 1.63638279 |
30 | PRKAA2 | 1.55109350 |
31 | INSRR | 1.53622989 |
32 | MKNK1 | 1.44991099 |
33 | FER | 1.39262962 |
34 | EEF2K | 1.36502649 |
35 | MAP4K2 | 1.34911516 |
36 | PRKD3 | 1.33254081 |
37 | MYLK | 1.28819338 |
38 | SYK | 1.28699866 |
39 | NEK9 | 1.28022674 |
40 | MAPK7 | 1.26976186 |
41 | PBK | 1.25913627 |
42 | CDK6 | 1.22238691 |
43 | MET | 1.19468106 |
44 | JAK1 | 1.18798752 |
45 | BRSK2 | 1.10121442 |
46 | MAPKAPK5 | 1.08486351 |
47 | PTK2B | 1.07827814 |
48 | TBK1 | 1.07097537 |
49 | LATS2 | 1.06590571 |
50 | CDK9 | 1.04486965 |
51 | ERN1 | 1.04022345 |
52 | PHKG1 | 1.01602177 |
53 | PHKG2 | 1.01602177 |
54 | PDGFRB | 1.01447819 |
55 | CCNB1 | 1.01356480 |
56 | MAP2K1 | 0.99368014 |
57 | PRKCH | 0.99180654 |
58 | BLK | 0.96791512 |
59 | BMPR2 | 0.96477791 |
60 | BTK | 0.86555636 |
61 | MTOR | 0.85557835 |
62 | PAK2 | 0.84360697 |
63 | PKN2 | 0.82297679 |
64 | RPS6KL1 | 0.82185757 |
65 | RPS6KC1 | 0.82185757 |
66 | MAPK4 | 0.81617226 |
67 | PDPK1 | 0.81272806 |
68 | AKT3 | 0.81219682 |
69 | ZAP70 | 0.80515616 |
70 | FGFR1 | 0.80427750 |
71 | RET | 0.79421208 |
72 | CAMKK2 | 0.78190339 |
73 | CDK8 | 0.76506924 |
74 | PRKAA1 | 0.76050324 |
75 | TRPM7 | 0.75562965 |
76 | PRPF4B | 0.75045996 |
77 | WNK1 | 0.73353255 |
78 | PRKD1 | 0.72295806 |
79 | RPS6KA6 | 0.72163512 |
80 | NUAK1 | 0.71566362 |
81 | FGFR4 | 0.71147038 |
82 | EIF2AK3 | 0.70874653 |
83 | IGF1R | 0.70592267 |
84 | NME2 | 0.69453771 |
85 | ITK | 0.69209221 |
86 | ILK | 0.68634909 |
87 | RPS6KA2 | 0.68606493 |
88 | HIPK2 | 0.68464592 |
89 | MAPK3 | 0.68404217 |
90 | EIF2AK2 | 0.67277319 |
91 | STK3 | 0.66968304 |
92 | PAK4 | 0.64751741 |
93 | MAP3K6 | 0.63359811 |
94 | KDR | 0.63345384 |
95 | MAP2K2 | 0.62509887 |
96 | INSR | 0.62001897 |
97 | GSK3A | 0.60222548 |
98 | ROCK1 | 0.59843758 |
99 | MAPKAPK3 | 0.59215667 |
100 | DMPK | 0.58176783 |
101 | BMPR1B | 0.57603559 |
102 | PAK3 | 0.56178617 |
103 | PDK1 | 0.55341852 |
104 | BMX | 0.54531798 |
105 | ADRBK1 | 0.54485926 |
106 | JAK2 | 0.53458552 |
107 | HCK | 0.52453147 |
108 | DAPK3 | 0.52061860 |
109 | DAPK2 | 0.51176464 |
110 | PTK6 | 0.50695888 |
111 | MAP3K14 | 0.50628559 |
112 | MARK2 | 0.49345259 |
113 | PRKACG | 0.48711497 |
114 | CDK3 | 0.47465607 |
115 | PRKD2 | 0.46999678 |
116 | RPS6KA5 | 0.46998513 |
117 | SRC | 0.44997870 |
118 | OBSCN | 0.44488053 |
119 | LCK | 0.43499802 |
120 | LRRK2 | 0.42636477 |
121 | MAPK1 | 0.41981874 |
122 | STK38 | 0.41226157 |
123 | CSF1R | 0.41140151 |
124 | CDK7 | 0.40678187 |
125 | EPHA3 | 0.39542880 |
126 | ADRBK2 | 0.37685530 |
127 | ABL2 | 0.36885664 |
128 | PRKG2 | 0.35931852 |
129 | MAPK12 | 0.35866963 |
130 | PTK2 | 0.35327292 |
131 | IKBKB | 0.34182808 |
132 | PINK1 | 0.34160839 |
133 | NTRK1 | 0.34131409 |
134 | RPS6KB1 | 0.33738661 |
135 | MAPK11 | 0.33718810 |
136 | CAMK1 | 0.32369367 |
137 | STK11 | 0.30039496 |
138 | TGFBR1 | 0.29299364 |
139 | CSK | 0.28745750 |
140 | CDK4 | 0.27145635 |
141 | PRKCE | 0.26911467 |
142 | MAP3K7 | 0.24871175 |
143 | ABL1 | 0.23991647 |
144 | SCYL2 | 0.23886574 |
145 | JAK3 | 0.21589196 |
146 | GRK5 | 0.21357532 |
147 | AKT1 | 0.20831958 |
148 | AKT2 | 0.20607421 |
149 | TYRO3 | 0.20523845 |
150 | STK38L | 0.20255938 |
151 | SGK3 | 0.19270860 |
152 | FLT3 | 0.18114005 |
153 | MAP3K2 | 0.15883552 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.88857739 |
2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 4.27259198 |
3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.21519973 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.99358236 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.34755044 |
6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.10017713 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.02545026 |
8 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.68514131 |
9 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.68188980 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59780432 |
11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.56254978 |
12 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.33565820 |
13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.24323018 |
14 | AMPK signaling pathway_Homo sapiens_hsa04152 | 2.16632426 |
15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.15646174 |
16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.97047745 |
17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90846847 |
18 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.82707297 |
19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70264046 |
20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.66287193 |
21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.61833206 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52427980 |
23 | Focal adhesion_Homo sapiens_hsa04510 | 1.51422912 |
24 | Asthma_Homo sapiens_hsa05310 | 1.51228525 |
25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47683808 |
26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42352014 |
27 | Insulin resistance_Homo sapiens_hsa04931 | 1.40085936 |
28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36272669 |
29 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.34202996 |
30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31866507 |
31 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.25319352 |
32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22968435 |
33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22012311 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.19163314 |
35 | Renin secretion_Homo sapiens_hsa04924 | 1.14721589 |
36 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.13002025 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11895275 |
38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09141018 |
39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05697339 |
40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.03813248 |
41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02430271 |
42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.01995638 |
43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01677868 |
44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97527035 |
45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94888236 |
46 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94773050 |
47 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92485808 |
48 | Amoebiasis_Homo sapiens_hsa05146 | 0.89728511 |
49 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86748188 |
50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85846829 |
51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84397337 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84147272 |
53 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.83845396 |
54 | Long-term depression_Homo sapiens_hsa04730 | 0.82416668 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81776465 |
56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.81473123 |
57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81234125 |
58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80872643 |
59 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80767525 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80145886 |
61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79761182 |
62 | Adherens junction_Homo sapiens_hsa04520 | 0.79513342 |
63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77098074 |
64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76706597 |
65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76324174 |
66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75463217 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73968653 |
68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71346061 |
69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70731496 |
70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68423934 |
71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68212060 |
72 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67838160 |
73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67712768 |
74 | Gap junction_Homo sapiens_hsa04540 | 0.67664288 |
75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66902873 |
76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66506065 |
77 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.66174378 |
78 | Ribosome_Homo sapiens_hsa03010 | 0.65068988 |
79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.64116207 |
80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63460773 |
81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62023061 |
82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59504696 |
83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59051409 |
84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58644256 |
85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57608002 |
86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57388340 |
87 | Purine metabolism_Homo sapiens_hsa00230 | 0.56583257 |
88 | Allograft rejection_Homo sapiens_hsa05330 | 0.54998707 |
89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53731327 |
90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53688825 |
91 | Platelet activation_Homo sapiens_hsa04611 | 0.51855680 |
92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51807272 |
93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51718724 |
94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50649411 |
95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50550433 |
96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49289478 |
97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48563250 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48199289 |
99 | Tight junction_Homo sapiens_hsa04530 | 0.47613385 |
100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46682430 |
101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.43815035 |
102 | Lysine degradation_Homo sapiens_hsa00310 | 0.43807155 |
103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43515869 |
104 | Melanoma_Homo sapiens_hsa05218 | 0.42616311 |
105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42430737 |
106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41999064 |
107 | ABC transporters_Homo sapiens_hsa02010 | 0.41667967 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40750106 |
109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40300184 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38201633 |
111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37999620 |
112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37617154 |
113 | Malaria_Homo sapiens_hsa05144 | 0.37444041 |
114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36252603 |
115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36103509 |
116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36001658 |
117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35347259 |
118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35127499 |
119 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35064454 |
120 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34779507 |
121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33857227 |
122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33753284 |
123 | Influenza A_Homo sapiens_hsa05164 | 0.33188417 |
124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32552304 |
125 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32057773 |
126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31928199 |
127 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31432840 |
128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.31134918 |
129 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30956810 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29936778 |
131 | Glioma_Homo sapiens_hsa05214 | 0.29002795 |
132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28561104 |
133 | Salivary secretion_Homo sapiens_hsa04970 | 0.27826792 |
134 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26738512 |
135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26222282 |
136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26082368 |
137 | Axon guidance_Homo sapiens_hsa04360 | 0.25988771 |
138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25631929 |
139 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25609288 |
140 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24477650 |
141 | Melanogenesis_Homo sapiens_hsa04916 | 0.23474720 |
142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23061818 |
143 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.22921182 |
144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22441635 |
145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.21928270 |
146 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21701013 |
147 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.19589169 |
148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19435515 |
149 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.19150852 |